Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	26.69	-674.56	532.44
Graham Fair Price	-79.28	1.19	5.76
PEG	237755.74	0.39	< 0.005
Price/Book	-15.92	3.75	4.46
Price/Cash Flow	-84.07	60.05	376.92
Prices/Earnings	-2136.61	-37.13	-1.66
Price/Sales	13.11	9.99	8.83
Price/FCF	-84.07	60.05	376.92
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-53.40	0.12	0.26
Operating Margin	94.22	-0.06	-0.99
ROA	96.26	< 0.005	-0.20
ROE	-0.67	-0.03	96.24
ROIC	-0.29	-0.01	96.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.02	-10.81
Dividends QOQ	-0.55	-0.42	24.76
EBIT QOQ	-108.90	0.96	-99.12
EPS QOQ	-102.09	0.96	-99.06
FCF QOQ	-0.64	4.10	544.89
Revenue QOQ	0.15	-0.28	84.96
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	232.50	264.17	13.62
Days Sales Outstanding (DSO)	71.94	101.70	41.37
Inventory Turnover	0.39	0.34	-11.99
Debt/Capitalization	0.56	0.56	0.39
Quick Ratio	0.30	0.29	-2.44
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.48	1.58	6.88
Cash	0.39	0.36	-6.68
Capex	-0.09	-0.02	73.58
Free Cash Flow	0.02	0.10	464.09
Revenue	0.75	0.59	-20.55
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.76	0.77	0.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	98.67	-142.16	44.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating